When I first met him, he immediately wanted to introduce me to this incredible woman, Sarah Morgan, which Sarah, by the way, like literally the praises he sung of you were just absolutely beautiful
It is not yet FDA-approved but may seek approval in 2026-2027
Methodology: Infants with suspected non-IgE mediated CMA received test or control formula
Manufacturers Responsibility to Warn of Potential Risks Drug manufacturers are obligated to disclose known and reasonably foreseeable risks associated with their medications
* Based on the trial product estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and took no other weight loss therapies
Temperature: Occasionally, if IV fluids are colder than your body temperature, you may feel chills or discomfort